Source link : https://newshealth.biz/health-news/first-car-t-cell-therapy-for-marginal-zone-lymphoma-gets-fda-green-light/
(MedPage Today) — Patients with advanced marginal zone lymphoma (MZL) now have a CAR T-cell therapy with the FDA approval of lisocabtagene maraleucel (liso-cel, Breyanzi). Approval was supported by findings from the TRANSCEND FL trial and stipulates… Source link : https://www.medpagetoday.com/hematologyoncology/lymphoma/118859 Author : Publish date : 2025-12-05 18:25:00 Copyright for syndicated content belongs to the […]
The post First CAR T-Cell Therapy for Marginal Zone Lymphoma Gets FDA Green Light first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-05 18:25:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8